| Background & aims
In our previous study, a Seesaw model was proposed for the fluctuation of crucial anti-
(IL-10) and pro-inflammatory (Il-6 & IL-17A) cytokines through vitamin D3. In this paper,
however, it is intended to extend the mentioned model by assessing the expression mRNA
levels of IL-27 and TGF-β1 as well as the changes of plasma levels of IL-27, TGF-β1, IL-
17A, IL-10, and IL-6 after treatment by vitamin D3.
Method
Venous blood samples were drawn from Healthy Participants (HP, n = 25) and First-Degree
Relative Participants (FDRP, n = 25) as control groups and Multiple Sclerosis Participants
(MSP, n = 25) before and after eight weeks of supplementation with 50000 IU vitamin D3.
The mRNA expression and plasma concentrations were gauged by using Real-Time PCR
and ELISA assay, respectively.
Results
The mRNA surfaces of IL-27, as well as TGF-β1, were up-regulated. However, the plasma
levels of TGF-β1, IL-17A, and IL-6 were significantly different among the three groups. In
addition, the plasma levels of IL-27, TGF-β1, IL-10, IL-17A, and IL-6 significantly changed
following the administration of vitamin D3.
Conclusion
The findings of this paper illustrate that anti-inflammatory cytokines could have a key role in
immunomodulatory functions due to their anti-inflammatory functions. To conclude, this
might contribute to preventing the pathophysiological process of MS. Also, the proposedmodel could be used as a preventive way on disposed people to multiple sclerosis, particularly in first degree relatives of these patients. |